Evidence map›Paper›PMID 35242505›Full record

ArticlePreventive medicine reports2022

Dynamics of COVID-19 in Amazonia: A history of government denialism and the risk of a third wave.

Lucas Ferrante, Luiz Henrique Duczmal, Eduardo Capanema, Wilhelm Alexander Cardoso Steinmetz, Alexandre Celestino Leite Almeida, Jeremias Leão, Ruth Camargo Vassão, Philip Martin Fearnside, Unaí Tupinambás

Open access · goldAbstract read
In one paragraph

Article in Preventive medicine reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Observational
  5. Article
  6. The future of Brazilian science.Nature human behaviour · 2023
    Article
  7. Global Human Threat: The Potential Synergism between Mercury Intoxication and COVID-19.International journal of environmental research and public health · 2023
    Article
  8. Article
  9. Hospitalizations for COVID-19 in a tertiary hospital in Brazil: a parallel with vaccination.Revista do Instituto de Medicina Tropical de Sao Paulo · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Lucas FerranteInstituto Nacional de Pesquisas da Amazônia (INPA), Programa de Pós-Graduação em Biologia (Ecologia), Manaus, Amazonas, Brazil.
Luiz Henrique DuczmalUniversidade Federal de Minas Gerais (UFMG), Department of Statistics, Belo Horizonte, Minas Gerais, Brazil.
Eduardo CapanemaUniversidade Federal de Minas Gerais (UFMG), Course of Computational Mathematics, Belo Horizonte, Minas Gerais, Brazil.
Wilhelm Alexander Cardoso SteinmetzUniversidade Federal do Amazonas (UFAM), Department of Mathematics, Manaus, Amazonas, Brazil.
Alexandre Celestino Leite AlmeidaUniversidade Federal de São João del-Rei (UFSJ), DEFIM, Ouro Branco, Minas Gerais, Brazil.
Jeremias LeãoUniversidade Federal do Amazonas (UFAM), Department of Statistics, Manaus, Amazonas, Brazil.
Ruth Camargo VassãoRetired from the Cell Biology Laboratory of the Instituto Butantan - São Paulo, São Paulo, Brazil.
Philip Martin FearnsideInstituto Nacional de Pesquisas da Amazônia (INPA), Coordenação de Pesquisa em Dinâmica Ambiental, Manaus, Amazonas, Brazil.
Unaí TupinambásUniversidade Federal de Minas Gerais (UFMG), Department of Internal Medicine, Belo Horizonte, Minas Gerais, Brazil.
Universidade Federal de Minas Gerais · BRNational Institute of Amazonian Research · BRUniversidade Federal do Amazonas · BRFederal University of São João del-Rei · BRInstituto Butantan · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The city of Manaus (the capital of Brazil's state of Amazonas) has become a key location for understanding the dynamics of the global pandemic of COVID-19. Different groups of scientists have foreseen different scenarios, such as the second wave or that Manaus could escape such a wave by having reached herd immunity. Here we test five hypotheses that explain the second wave of COVID-19 in Manaus: 1) The greater transmissibility of the Amazonian (gamma or P.1) variant is responsible for the second wave; 2) SARS-CoV-2 infection levels during the first wave were overestimated by those foreseeing herd immunity, and the population remained below this threshold when the second wave began at the beginning of December 2020; 3) Antibodies acquired from infection by one lineage do not confer immunity against other lineages; 4) Loss of immunity has generated a feedback phenomenon among infected people, which could generate future waves, and 5) A combination of the foregoing hypotheses. We also evaluated the possibility of a third wave in Manaus despite advances in vaccination, the new wave being due to the introduction of the delta variant in the region and the loss of immunity from natural contact with the virus. We developed a multi-strain SEIRS (Susceptible-Exposed-Infected-Removed-Susceptible) model and fed it with data for Manaus on mobility, COVID-19 hospitalizations, numbers of cases and deaths. Our model contemplated the current vaccination rates for all vaccines applied in Manaus and the individual protection rates already known for each vaccine. Our results indicate that the SARS-CoV-2 gamma (P.1) strain that originated in the Amazon region is not the cause of the second wave of COVID-19 in Manaus, but rather this strain originated during the second wave and became predominant in January 2021. Our multi-strain SEIRS model indicates that neither the doubled transmission rate of the gamma variant nor the loss of immunity alone is sufficient to explain the sudden rise of hospitalizations in late December 2020. Our results also indicate that the most plausible explanation for the current second wave is a SARS-CoV-2 infection level at around 50% of the population in early December 2020, together with loss of population immunity and early relaxation of restrictive measures. The most-plausible model indicates that contact with one strain does not provide protection against other strains and that the gamma variant has a transmissibility rate twice that of the original SARS-CoV-2 strain. Our model also shows that, despite the advance of vaccination, and even if future vaccination advances at a steady pace, the introduction of the delta variant or other new variants could cause a new wave of COVID-19.

Indexed as

BrazilCoronavirusDelta variantEpidemiologyGamma variantImmunity lossManausMulti-strain SEIRS modelPandemicPublic healthPublic health policyReinfectionSARS-CoV-2Transmissibility

Identifiers

PMID35242505
PMCPMC8883727
OpenAlexW4214749767

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.